Low-dose aspirin, coxibs, and other NSAIDS: a clinical mosaic emerges.

Low-dose aspirin, coxibs, and other NSAIDS: a clinical mosaic emerges.

Aspirin has been a commercial drug for over a century, although for most of this history, an understanding of its mechanism of action, as an inhibitor of cyclooxygenase (COX) activity and thus of prostanoid synthesis, was lacking. Over the past fifty years, a large number of other nonsteroidal antii...

書誌詳細
主要な著者:	Patrono, C, Baigent, C
フォーマット:	Journal article
言語:	English
出版事項:	2009

類似資料

Coxibs and traditional NSAIDs for pain relief - Authors' reply.
著者:: Bhala, N, 等
出版事項: (2014)

Coxibs and traditional NSAIDs for pain relief - Authors' reply.
著者:: Bhala, N, 等
出版事項: (2014)

Review: NSAIDs increase GI and CV events; coxibs increase mortality
著者:: Baigent, C
出版事項: (2013)

Coxibs, traditional NSAIDs and cardiovascular safety post-PRECISION: What we thought we knew then and what we think we know now
著者:: Patrono, C, 等
出版事項: (2017)

Low-dose aspirin for the prevention of atherothrombosis.
著者:: Patrono, C, 等
出版事項: (2005)

Drug therapy - Low-dose aspirin for the prevention of atherothrombosis
著者:: Patrono, C, 等
出版事項: (2005)

ASA, NSAIDs, Coxibs and Colorectal Cancer Prevention — How Far Have We Come?
著者:: Martin Fishman
出版事項: (2004-01-01)

Antiplatelet therapy: aspirin for asymptomatic atherosclerosis?
著者:: Patrono, C, 等
出版事項: (2010)

Role of aspirin in primary prevention of cardiovascular disease
著者:: Patrono, C, 等
出版事項: (2019)

Nonsteroidal anti-inflammatory drugs (NSAIDs), cyxlooxygenase-2 selective inhibitors (coxibs) and gastrointestinal harm: review of clinical trials and clinical practice
著者:: Moore, R, 等
出版事項: (2006)

Selective cyclooxygenase 2 inhibitors, aspirin, and cardiovascular disease: a reappraisal.
著者:: Baigent, C, 等
出版事項: (2003)

Nonsteroidal anti-inflammatory drugs (NSAIDs), cyxlooxygenase-2 selective inhibitors (coxibs) and gastrointestinal harm: review of clinical trials and clinical practice
著者:: Phillips Ceri J, 等
出版事項: (2006-10-01)

Pharmacoutilization of anti-inflammatory and gastroprotective drugs in patients with osteoarthritis: comparison between COXIBs and conventional NSAIDs by using administrative records
著者:: Luca Degli Esposti, 等
出版事項: (2006-01-01)

Gastric and renal effects of COX-2 selective and non-selective NSAIDs in rats receiving low-dose aspirin therapy
著者:: Marcella Goetz MORO, 等

Aspirin Actions in Treatment of NSAID-Exacerbated Respiratory Disease
著者:: Esha Sehanobish, 等
出版事項: (2021-06-01)

Results of the PRECISION study: Could an answer be given to the question of how safe coxibs versus traditional NSAIDs are in treating patients at high risk for cardiovascular events?
著者:: E. V. Dovgan
出版事項: (2017-09-01)

Cardiac toxicity of coxibs: mechanisms of development and their prevention
著者:: O O Yakovleva, 等
出版事項: (2018-11-01)

Opinion - Coxibs: can this class of drugs survive?
著者:: Reza Tabrizchi
出版事項: (2005-04-01)

COX-2 SPECIFIC INHIBITORS (COXIBS) CRISIS
著者:: Abbas Ali Mansour
出版事項: (2003-12-01)

What is safer for the gastrointestinal-tract: Coxibs or meloxicam?
著者:: A. M. Satybaldyev, 等
出版事項: (2017-03-01)

Pathogenesis of NSAID-induced reactions in aspirin-exacerbated respiratory disease
著者:: Tanya M. Laidlaw
出版事項: (2018-09-01)

NSAIDs, Mitochondria and Calcium Signaling: Special Focus on Aspirin/Salicylates
著者:: Yoshihiro Suzuki, 等
出版事項: (2010-05-01)

Rofecoxib-Induced Hepatotoxicity: A Forgotten Complication of the Coxibs
著者:: Brian Yan, 等
出版事項: (2006-01-01)

The adverse effects of different doses of aspirin: a systematic overview of randomised trials and observational studies
著者:: Sudlow, G, 等
出版事項: (2000)

Low-dose aspirin for migraine prophylaxis.
著者:: Buring, J, 等
出版事項: (1990)

COX-2 inhibitors and the heart: are all coxibs the same?
著者:: Sooriakumaran, P
出版事項: (2006)

Determination of the prevalence of clinical signs of Aspirin and NSAID poisoning in patients referring to Ahvaz Razi Hospital
著者:: Maryam Shirani, 等
出版事項: (2022-09-01)

Benefit of heparin plus aspirin vs aspirin alone in unstable angina.
著者:: Collins, R, 等
出版事項: (1996)

Aspirin for everyone older than 50? Against.
著者:: Baigent, C
出版事項: (2005)

Monoclonal antibody or aspirin desensitization in NSAID-exacerbated respiratory disease (N-ERD)?
著者:: Dorien Van Broeck, 等
出版事項: (2023-04-01)

Faecal blood loss: Systematic review and analysis of randomised trials with aspirin and NSAIDs
著者:: Moore, A, 等
出版事項: (2007)

LOW-DOSE ASPIRIN IN PREGNANCY AND EARLY-CHILDHOOD DEVELOPMENT - FOLLOW-UP OF THE COLLABORATIVE LOW-DOSE ASPIRIN STUDY IN PREGNANCY
著者:: Farrell, B, 等
出版事項: (1995)

Aspirin for disease prevention: public policy or personal choice?
著者:: Baigent, C
出版事項: (2016)

Variability in aspirin efficacy: all in the genes?
著者:: Baigent, C, 等
出版事項: (2019)

Efficacy and safety of simvastatin and safety of low-dose aspirin among patients with chronic kidney disease: Final results of the first UK-Heart and Renal Protection (UK-HARP-1) study.
著者:: Baigent, C, 等
出版事項: (2002)

Farmacoeconomia dei COXIB nella patologia osteoarticolare: revisione della letteratura
著者:: Pierluigi Russo, 等
出版事項: (2003-05-01)

Aspirin, platelet inhibition and cancer prevention
著者:: Paola Patrignani, 等
出版事項: (2018-11-01)

Aspirin at 120: Retiring, recombining, or repurposing?
著者:: Carlo Patrono, 等
出版事項: (2021-05-01)

3437 Associations of aspirin, non-aspirin NSAIDs, statins, and metformin with risk of biliary cancer: A Swedish population-based cohort study
著者:: Lorena Marcano Bonilla, 等
出版事項: (2019-03-01)

Quality of Life in NSAIDs-Exacerbated Respiratory Disease on or off Intranasal Lysine Aspirin Therapy
著者:: Alfonso Luca Pendolino, 等
出版事項: (2024-01-01)